www.drugwatch.com

Share

www.drugwatch.com

 •  November 8, 2017

A bill before Congress would allow the Defense Department instead of the FDA to approve certain drugs and medical devices for deployed troops. Military leaders have pushed for faster approval of medical innovations, often complaining that the FDA process takes too long. Critics of the new plan, including congressional staff members working on the...

www.drugwatch.com

 •  October 2, 2017

In the past 10 years, the U.S. Food and Drug Administration has received more than 5.4 million reports of serious adverse events associated with medications, including more than 1 million deaths. Until now, it was difficult for people to find out how many of those reports applied to a drug they were taking. The FDA has launched a new Public...

www.drugwatch.com

 •  September 6, 2017

Evidence used to support the government’s approval of some prescription drugs suffers from “major flaws,” according to the findings of two new studies. Specifically, researchers found that drugs cleared through the U.S. Food and Drug Administration’s accelerated-approval process often lack quality clinical studies to demonstrate their...

www.drugwatch.com

 •  May 4, 2017

A federal jury in New Orleans recently sided with drugmakers Bayer AG and Johnson & Johnson in the first bellwether trial from plaintiffs alleging they were harmed by the blood-thinning drug Xarelto. Joseph Boudreaux, 75, of Louisiana blamed the drugmakers for life-threatening bleeding after taking the drug. He is the first in a series of four...